rs144693254

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7

The NM_173354.5(SIK1):​c.1470C>T​(p.Val490Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: not found (cov: 0)
Exomes 𝑓: 0.00032 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

SIK1
NM_173354.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.573

Publications

1 publications found
Variant links:
Genes affected
SIK1 (HGNC:11142): (salt inducible kinase 1) This gene encodes a serine/threonine protein kinase that contains a ubiquitin-associated (UBA) domain. The encoded protein is a member of the adenosine monophosphate-activated kinase (AMPK) subfamily of kinases that play a role in conserved signal transduction pathways. A mutation in this gene is associated with early infantile epileptic encephalopathy 30. [provided by RefSeq, Nov 2016]
SIK1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 30
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • early myoclonic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • generalized epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 21-43418534-G-A is Benign according to our data. Variant chr21-43418534-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 476085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.573 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SIK1NM_173354.5 linkc.1470C>T p.Val490Val synonymous_variant Exon 12 of 14 ENST00000270162.8 NP_775490.2
SIK1XM_011529474.3 linkc.1323C>T p.Val441Val synonymous_variant Exon 11 of 13 XP_011527776.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SIK1ENST00000270162.8 linkc.1470C>T p.Val490Val synonymous_variant Exon 12 of 14 1 NM_173354.5 ENSP00000270162.6

Frequencies

GnomAD3 genomes
Cov.:
0
GnomAD2 exomes
AF:
0.00466
AC:
1124
AN:
240954
AF XY:
0.00521
show subpopulations
Gnomad AFR exome
AF:
0.000704
Gnomad AMR exome
AF:
0.000756
Gnomad ASJ exome
AF:
0.0249
Gnomad EAS exome
AF:
0.000165
Gnomad FIN exome
AF:
0.00524
Gnomad NFE exome
AF:
0.00299
Gnomad OTH exome
AF:
0.00574
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000321
AC:
1
AN:
3118
Hom.:
0
Cov.:
0
AF XY:
0.000593
AC XY:
1
AN XY:
1686
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
134
American (AMR)
AF:
0.00
AC:
0
AN:
452
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
62
East Asian (EAS)
AF:
0.00
AC:
0
AN:
72
South Asian (SAS)
AF:
0.00167
AC:
1
AN:
600
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
10
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1598
Other (OTH)
AF:
0.00
AC:
0
AN:
152
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
0
Alfa
AF:
0.00483
Hom.:
2
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.00333
EpiControl
AF:
0.00308

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SIK1: BP4, BP7 -

Inborn genetic diseases Benign:1
May 03, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy, 30 Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
2.0
DANN
Benign
0.81
PhyloP100
0.57
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144693254; hg19: chr21-44838414; API